Related Experiment Videos
Acute interferon-alpha administration modulates sucrose consumption in the rat
S Sammut1, G Goodall, R Muscat
1Department of Biomedical Sciences, Laboratory of Behavioural Neuroscience, University of Malta, Msida, Malta. s.sammut@biotech.um.edu.mt
Psychoneuroendocrinology
|February 13, 2001
Summary
Interferon-alpha (IFN-alpha) administration induced anhedonia, a key symptom of depression, in rats. Sucrose consumption, a measure of reward sensitivity, was significantly reduced by IFN-alpha, confirming its depression-like effects.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Anhedonia, a core symptom of depression, signifies a loss of interest or pleasure.
- Sucrose consumption serves as a validated indicator of reward sensitivity.
Purpose of the Study:
- To investigate the anhedonic effects of interferon-alpha (IFN-alpha) in a rodent model.
- To assess changes in sucrose consumption as a measure of IFN-alpha-induced anhedonia.
Main Methods:
- Rats were administered varying doses of Recombinant Human Interferon-alphaA (rHIFN-alpha) and Rat Interferon alpha (rRIFN-alpha).
- Sucrose consumption was measured using a three-bottle test with 1%, 8%, and 32% sucrose solutions.
- Drinking rate and body temperature were monitored following different pre-treatment times.
Main Results:
- Both rHIFN-alpha and rRIFN-alpha decreased sucrose consumption and drinking rate at higher doses, particularly at the lowest sucrose concentration (1%).
- Pre-treatment times of 40 and 80 minutes showed insignificant effects on sucrose consumption.
- Significant hypothermia was observed with a 20-minute pre-treatment, but not with longer durations.
Conclusions:
- IFN-alpha administration induces anhedonia, a depression-like behavioral syndrome in rats.
- The observed effects on reward sensitivity are dose-dependent and influenced by pre-treatment timing.